Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

TB Guidelines

Listed by Date

On this page —

Listed by Date MMWR
Title Format Date Published
Update of Recommendations for Use of Once-Weekly Isoniazid-Rifapentine Regimen to Treat Latent Mycobacterium tuberculosis Infection
MMWR 2018; 67:723-726
PDF
(94 KB)
06/2018
Diagnosis of Tuberculosis in Children and Adults
Clinical Infectious Disease 2017
PDF
(2.83 MB)
01/2017
Treatment of Drug-Susceptible Tuberculosis
Clinical Infectious Disease 2016
PDF
(1MB)
08/2016
Provisional CDC Guidelines for the Use and Safety Monitoring of Bedaquiline Fumarate (Sirturo) for the Treatment of Multidrug-Resistant Tuberculosis
MMWR 2013; 62 (No. 9)
PDF
(411 KB)
10/2013
Availability of an Assay for Detecting Mycobacterium tuberculosis, Including Rifampin-Resistant Strains, and Considerations for Its Use — United States, 2013
MMWR 2013; 62 (No. 41)
PDF
(275 KB)
10/2013
Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis PDF
(229 KB)
6/2013
Recommendations for Use of an Isoniazid–Rifapentine Regimen with Direct Observation to Treat Latent Mycobacterium tuberculosis Infection
MMWR 2011; 60:1650–1653
PDF
(1.1 MB)
12/2011
Updated Guidelines for Using Interferon Gamma Release Assays to Detect Mycobacterium tuberculosis Infection — United States, 2010
MMWR 2010; 59 (RR-5); 1-25
PDF
(502 KB)
6/2010
Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children
MMWR
2009; 58: 1-166
PDF
(2.2 MB)
3/2009
Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents
MMWR 2009; 58: 1-198
PDF
(2.2 MB)
3/2009
Plan to Combat Extensively Drug-Resistant Tuberculosis
MMWR 2009; 58 (RR-03)
PDF
(752 KB)
2/2009
Updated Guidelines for the Use of Nucleic Acid Amplification Tests in the Diagnosis of Tuberculosis
MMWR 2009; 58 (01); 7-10
PDF
(1.2 MB)
1/2009
Report of Expert Consultations on Rapid Molecular Testing to Detect Drug-Resistant Tuberculosis in the United States 11/2008
Report of an Expert Consultation on the Uses of Nucleic Acid Amplification Tests for the Diagnosis of Tuberculosis 11/2008
Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC
MMWR 2006; 55 (No. RR–09, 1–44)
PDF
(589 KB)
7/2006
Guidelines for Preventing the Transmission of Mycobacterium tuberculosis in Health-Care Settings, 2005
MMWR
2005; 54 (No. RR-17) – Reprint
Note: The errata was removed. The corrections included in the errata have been incorporated into the reprinted guidelines.

PDF
(4.2 MB)12/2005

Health Information for International Travel

1/2005
–2006Guidelines for Using the QuantiFERON–TB Gold Test for Detecting Mycobacterium tuberculosis Infection, United States
MMWR 2005; 54 (No. RR–15, 1–37)PDF
(544 KB)12/2005Guidelines for the Investigation of Contacts of Persons with Infectious Tuberculosis: Recommendations from the National Tuberculosis Controllers Association and CDC
MMWR
2005; 54 (No. RR–15, 1–37)PDF
(544 KB)12/2005Controlling Tuberculosis in the United States
Recommendations from the American Thoracic Society, CDC, and the Infectious Diseases Society of America
MMWR 2005; 54 (No. RR–12)PDF
(1.1 MB)11/2005National Plan for Reliable Tuberculosis Laboratory Services Using a Systems Approach
MMWR
2005; 54 (RR–6)PDF
(186 KB)4/2005Errata: Treatment of Tuberculosis
MMWR 2005; 52 (RR–11)PDF
(499 KB)1/2005New CDC Program for Rapid Genotyping of Mycobacterium tuberculosis Isolates
MMWR 2005; 54 (No. 02)PDF
(483 KB)1/2005Treating Opportunistic Infections Among HIV–Infected Adults and Adolescents
MMWR 2004; 53 (RR15)PDF
(1.9 MB)12/2004Treating Opportunistic Infections Among HIV–Exposed and Infected Children
MMWR 2004; 53 (RR14)PDF
(742 KB)12/2004Tuberculosis Associated with Blocking Agents Against Tumor Necrosis Factor – Alpha – California, 2002–2003
MMWR
2004; 53 (No. 30)PDF
(325 KB)8/2004Guide to the Application of Genotyping to Tuberculosis Prevention and ControlPDF
(763 KB)6/2004Update: Adverse Event Data and Revised American Thoracic Society/CDC Recommendations Against the Use of Rifampin and Pyrazinamide for Treatment of Latent Tuberculosis Infection
MMWR 2003; 52 (No. 31)PDF
(587 KB)8/2003Treatment of Tuberculosis
MMWR
2003; 52 (No. RR–11)

PDF
(1.5 MB)6/2003Guidelines for Environmental Infection Control in Health–Care Facilities
MMWR
2003; 52 (No. RR–10)PDF
(1.1 mB)6/2003Timing of Tuberculosis Screening and Smallpox Vaccination – Recommendations for Using Smallpox Vaccine in a Pre–Event Vaccination Program
MMWR
2003; 52 (No. RR–7)PDF
(237 KB)4/2003Guidelines for Preventing Opportunistic Infections Among HIV–Infected Persons — 2002
MMWR
2002; 51 (No. RR–8)PDF
(776 KB)6/2002Progressing Toward Tuberculosis Elimination in Low–Incidence Areas of the United States
MMWR
2002; 51 (No. RR–5)PDF
(329 KB)5/2002General Recommendations on Immunization: Recommendations of the Advisory Committee on Immunization Practices (ACIP) and the American Academy of Family Physicians (AAFP)
MMWR 2002; 51 (No. RR–2).PDF
(6.3 MB)2/2002Preventing and Controlling Tuberculosis Along the U.S.–Mexico Border Work Group Report
MMWR
2001; 50 (No. RR–1)PDF
(550 KB)1/2001Update: Nucleic Acid Amplification Tests for Tuberculosis
MMWR 2000; 49 (No. 26)PDF
(136 KB)7/2000Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection
MMWR
2000; 49 (No. RR–6)
UpdatesPDF
(350 KB)6/2000Updated Guidelines for the Use of Rifabutin or Rifampin for the Treatment and Prevention of Tuberculosis Among HIV–Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
MMWR
2000; 49 (No. 9)PDF
(241 KB)3/2000Diagnostic Standards and Classification of Tuberculosis in Adults and Children
Am J Respir Crit Care Med 2000; 161PDF
(168 KB)2000Tuberculosis Elimination Revisited: Obstacles, Opportunities, and a Renewed Commitment (ACET)
MMWR
1999; 48 (No. RR–9)PDF
(211 KB)8/1999Recommendations for Prevention and Control of Tuberculosis among Foreign–Born Persons
MMWR
1998; 47 (No. RR–16)PDF
(293 KB)9/1998Development of new Vaccines for Tuberculosis
MMWR
1998; 47 (No. RR–13)PDF
(171 KB)8/1998Nucleic Acid Amplification Tests for Tuberculosis.
MMWR 1996; 45 (No. 43)PDF
(303 KB)11/1996Prevention and Control of Tuberculosis in Correctional Facilities (ACET)
MMWR
1996; 45 (No. RR–8)PDF
(313 KB)6/1996The Role of BCG Vaccine in the Prevention and Control of Tuberculosis in the United States. (ACET and ACIP)
MMWR
1996; 45 (RR–4)PDF
(266 KB)4/1996Essential Components of a Tuberculosis Prevention and Control Program (ACET)
MMWR
1995; 44 (No. RR–11)PDF
(358 KB)9/1995Tuberculosis Control Laws – United States, 1993 (ACET)
MMWR
1993; 42 (No. RR–15)PDF
(253 KB)11/1993Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of Vaccines and Immune Globulins in Persons with Altered Immunocompetence
MMWR 1993; 42 (No. RR-4)PDF
(237 KB)04/1993

Archived TB Guidelines

Archived TB Guidelines MMWR 
Title Format Date Published
Notice to Readers: Updated Guidelines on Managing Drug Interactions in the Treatment of HIV-Related Tuberculosis
MMWR 2008; 57 (No. 4, 98)
PDF
(268 KB)
01/2008
Notice to Readers: Updated Guidelines for the Use of Rifamycins for the Treatment of Tuberculosis Among HIV–Infected Patients Taking Protease Inhibitors or Nonnucleoside Reverse Transcriptase Inhibitors
MMWR 2004; 53 (No. 2)
PDF
(346 KB)
1/2004
Guidelines for Using the QuantiFERON®–TB Test for Diagnosing Latent Mycobacterium tuberculosis Infection
MMWR
2002; 51 (12/18/02)
PDF
(398 KB)
1/2003
Public Health Dispatch: Update:
Fatal and Severe Liver Injuries Associated with Rifampin and Pyrazinamide Treatment for Latent Tuberculosis Infection
MMWR
2002; 51 (No. 44)
PDF
(1.7 MB)
11/2002
Diagnostic Standards and Classification of Tuberculosis in Adults and Children
Am J Respir Crit Care Med 2000; 161
PDF
168 KB)
7/1999
Prevention and Treatment of Tuberculosis among Patients Infected with Human Immunodeficiency Virus: Principles of Therapy and Revised Recommendations
MMWR 1998; 47 (No. RR–20)
PDF
(743 KB)
10/1998
Anergy Skin Testing and Preventive Therapy for HIV–Infected Persons: Revised Recommendations
MMWR
1997; 46 (No. RR–15)
PDF
(1.8 MB)
9/1997
Screening for Tuberculosis and Tuberculosis Infection in High–Risk Populations (ACET)
MMWR
1995; 44 (No. RR–11)
PDF
(358 KB)
9/1995
Guidelines for Preventing the transmission of Mycobacterium tuberculosis in Health–Care Facilities, 1994
MMWR
1994; 43 (No. RR–13)
PDF
(8.5 MB)
10/1994
Prevention and Control of Tuberculosis in Migrant Farm Workers (ACET)
MMWR
1992; 41 (No. RR–10)
N/A 6/1992
National Action Plan to Combat Multidrug–Resistant Tuberculosis
MMWR
1992; 41 (RR–11)
N/A 6/1992
Management of Persons Exposed to Multidrug–Resistant Tuberculosis
MMWR
1992; 41 (RR–11)
N/A 6/1992
Prevention and Control of Tuberculosis in U.S. Communities with At–Risk Minority Populations (ACET)
MMWR
1992; 41 (No. RR–5)
N/A 4/1992
Prevention and Control of Tuberculosis Among Homeless Persons (ACET)
MMWR
1992; 41 (No. RR–5)
N/A 4/1992
Prevention and Control of Tuberculosis in Facilities Providing Long–Term Care to the Elderly (ACET)
MMWR
1990; 39 (RR–10)
N/A 7/1990
A Strategic Plan for the Elimination of Tuberculosis in the United States
MMWR
1989; 38 (S–3).
N/A 4/1989

TOP
Error processing SSI file
Error processing SSI file